研究员，医学博士，博士研究生导师，现任中国疾病预防控制中心结控中心主任，国家参比实验室主任，国家疾病预防控制专家委员会委员，国家传染病标准专业委员会委员，国家卫生健康科普专家，世界卫生组织结核病诊断和实验室网络建设委员会常委，世界卫生组织全球结核病实验室行动组（GLI）科学委员会副主席，中国防痨协会常务理事，中华预防医学会呼吸病预防与控制专业委员会常务委员，中国防痨协会基础专业分会主任委员，中国医药生物技术协会实验室生物安全委员会常委，主持或者承担国家重点支持项目863、北京市科技新星项目、WHO科研合作项目、国家十一五、十二五和十三五传染病科技重大专项、国家重大基础研究计划（973项目）以及美国NIH研究RO1等多项课题。入选新世纪百千万人才工程“百层次”计划，获得省部级科技奖一等奖1项，二等奖2项；中华医学科技奖二等奖1项，中华预防医学奖三等奖1项，华夏医学科技奖二等奖1项，带领团队获得由中共中央组织部、中共中央宣传部、人力资源社会保障部、科学技术部联合评定的“全国专业技术人才先进集体”荣誉称号。在世界顶级医学杂志《新英格兰医学杂志》、《柳叶刀》等刊物中发表学术论文280余篇，主编出版学术专著26部。
代表性论著：
1. Zheng H, Wang Y, He W, Li F, Xia H, Xiao J, Ou X, Wang S, Shen C, Zhao Y.In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China. Microb Drug Resist. 2023 Jan 10. doi: 10.1089/mdr.2022.0216.
2. Ou X, Zhang Z, Zhao B, Song Z, Wang S, He W, Pei S, Liu D, Xing R, Xia H, Zhao Y. Evaluation Study of xMAP TIER Assay on a Microsphere-Based Platform for Detecting First-Line Anti-Tuberculosis Drug Resistance. Int J Environ Res Public Health. 2022 Dec 19;19(24):17068. doi: 10.3390/ijerph192417068.
3. Zhou L, Wu B, Huang F, Liu Z, Wang F, Zhang M, Chen B, Chen S, Wang X, Zhao Y.Drug resistance patterns and dynamics of tuberculosis in Zhejiang Province, China: Results from five periodic longitudinal surveys. Front Public Health. 2022 Nov 29;10:1047659. doi: 10.3389/fpubh.2022.1047659. eCollection 2022.
4. Li T, Yan X, Du X, Huang F, Wang N, Ni N, Ren J, Zhao Y, Jia Z. Extrapulmonary tuberculosis in China: a national survey. Int J Infect Dis. 2022 Dec 10;128:69-77. doi: 10.1016/j.ijid.2022.12.005.
5. Song Z, Liu Z, Ma A, Liu C, He W, Zeng X, Wang Y, He P, Liu D, Zhao B, Xia H, Wang S, Zhao Y. High diversity of clinical Mycobacterium intracellulare in China revealed by whole genome sequencing. Front Public Health. 2022 Nov 17;10:989587. doi: 10.3389/fpubh.2022.989587.
6. Zheng Y, Xia H, Bao X, Zhao B, He P, Zhao Y.Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium Tuberculosisby Droplet Digital PCR. Infect Drug Resist. 2022 Oct 28;15:6245-6254. doi: 10.2147/IDR.S381097
7. Luo L, Liang L, Zhang R, Chen W, Yu F, Zhao Y, Yue J . Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical
Microbiology Laboratory. Microbiol Spectr. 2022 Dec 21;10(6):e0201822. doi: 10.1128/spectrum.02018-22.
8. Cui Z, Huang F, Liang D, Huang Y, Qin H, Ye J, Huang L, Zhou C, Huang M, Liang X, Long F, Zhao Y, Lin M. Tuberculosis among Ambulatory People Living with HIV in Guangxi Province, China: A Longitudinal Study. Int J Environ Res Public Health. 2022 Sep 27;19(19):12280. doi: 10.3390/ijerph191912280.
9. Zhao B, Liu C, Fan J, Ma A, He W, Hu Y, Zhao Y .Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China. Microbiol Spectr. 2022 Oct 26;10(5):e0240521. doi: 10.1128/spectrum.02405-
10. Zhou Y, Anthony R, Wang S, Ou X, Liu D, Zhao Y, van Soolingen D. The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives. J Infect. 2022 Nov;85(5):609. doi: 10.1016/j.jinf.2022.09.013
11. The CRyPTIC Consortium. Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms. PLoS Biol. 2022 Aug 9;20(8):e3001755. doi: 10.1371/journal.pbio.3001755.
12. Dong Y, Feng Y, Ou X, Liu C, Fan W, Zhao Y, Hu Y, Zhou X. Genomic analysis of diversity, biogeography, and drug resistance in Mycobacterium bovis. Transbound Emerg Dis. 2022 Sep;69(5):e2769-e2778. doi: 10.1111/tbed.14628.
13, Li Y, Liu C, Ma A, He W, Qiu Q, Zhao Y, Li Y. Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China. J Glob Antimicrob Resist. 2022 Dec;31:90-97. doi: 10.1016/j.jgar.2022.05.027.
14. Dong Y, Ou X, Liu C, Fan W, Zhao Y, Zhou X. Diversity of glpK Gene and Its Effect on Drug Sensitivity in Mycobacterium bovis. Infect Drug Resist. 2022 Apr 2;15:1467-1475. doi: 10.2147/IDR.S346724.
15. Xia H, Song Y, Zheng Y, Wang S, Zhao B, He W, Liu D, Ou X, Zhou Y, Zhao Y. Detection of Mycobacterium tuberculosis Rifampicin Resistance Conferred by Borderline rpoB Mutations: Xpert MTB/RIF is Superior to Phenotypic Drug Susceptibility Testing. Infect Drug Resist. 2022 Mar 29;15:1345-1352. doi: 10.2147/IDR.S358301.
